Closed call · historical reference

H2020-JTI-IMI2-2017-12-two-stage · Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS)

Specific Challenge:Currently, published data from placebo-controlled and adequately powered clinical trials in primary Sjögren’s Syndrome (pSS) are scarce. Although specific novel, validated treatment outcome measures have been developed recently, e.g. the European League against Rheumatism (EULAR)…